热血素具有双重的素样和化学素样特异性
Bosko M Stojanovski1, Leslie A Pelc1, Enrico Di Cera1
1Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA.
Journal of thrombosis and haemostasis : JTH
|December 31, 2023
概括
凝血素在脊椎动物中激活C蛋白,甚至在光鱼中,裂变发生在 (Trp) 而不是 (Arg). 这项研究证实了激素的存在.
科学领域:
- 生物化学 生物化学
- 酶学 是一种酶学.
- 进化生物学 进化生物学
背景情况:
- 蛋白C激活通常涉及氨酸 (Arg) 分裂部位.
- 射 finned 鱼在这个地方拥有 (Trp) 残留物,这提出了一个进化问题.
- 脊椎动物中蛋白C的生理激活剂仍在研究中.
研究的目的:
- 为了确定血栓素是否可以分裂 (Trp) 残留物.
- 为了研究血栓素在光鱼中激活蛋白C的作用.
主要方法:
- 使用染色基质评估野生型血栓和D189S突变活性.
- 测试了血栓素对野生类型蛋白C和突变细胞的分裂,其中突变细胞的分裂部位发生了变化.
主要成果:
- 氨酸表现出双重氨酸样和化学氨酸样的特异性,在氨酸 (Arg) 和氨酸 (Trp) 残留物处分离基质.
- 血素对托芬 (Trp) 的裂变是显著的,可与基米托素相比较.
- 热血素在脊椎动物中激活C蛋白,包括光鱼,激活率受侧翼序列的影响.
- D189S突变体表现出广泛的特异性,在基本和芳香残留物上进行裂变.
结论:
- 这项研究支持血素作为所有脊椎动物中蛋白C的生理激活剂.
- 这些发现解决了三 (Trp) 在光鱼中蛋白C裂变部位的悖论.
- 血的双重特异性表明,生理基质的范围比以前认可的更广泛.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
702
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
702
Cholinesterases: Distribution and Function
466
Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
466
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
567
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
567


